Puma Biotechnology (PBYI) EBT (2010 - 2026)
Puma Biotechnology (PBYI) posted EBT of -$3.4 million for Q1 2026, down 120.03% on a QoQ basis from $17.1 million in Q4 2025, and down 204.9% year-over-year from $3.3 million in Q1 2025.
Puma Biotechnology (PBYI) EBT (2010 - 2026) Analysis & Trends
Puma Biotechnology's EBT history runs 17 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- Quarterly EBT fell 204.9% year-over-year to -$3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.1 million (up 269.98% YoY) and the FY2025 annual result came in at $35.8 million, changed N/A from the prior year.
- EBT was -$3.4 million for Q1 2026 at Puma Biotechnology, down from $17.1 million in the prior quarter.
- Across five years, EBT topped out at $20.6 million in Q3 2024 and bottomed at -$11.9 million in Q4 2024.
- A 5-year average of $3.3 million and a median of $2.3 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT surged 2150.85% — and 2024, when it sank 396.83%.
- Puma Biotechnology's EBT stood at -$5.3 million in 2022, then soared by 341.04% to $12.8 million in 2023, then plunged by 192.64% to -$11.9 million in 2024, then soared by 244.22% to $17.1 million in 2025, then sank by 120.03% to -$3.4 million in 2026.
- Business Quant data shows PBYI's EBT at -$3.4 million in Q1 2026, $17.1 million in Q4 2025, and $9.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | -3.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.43 Mn |
| Dec 31, 2025 | 17.11 Mn |
| Sep 30, 2025 | 9.24 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | -11.86 Mn |
| Sep 30, 2024 | 20.61 Mn |
| Jun 30, 2024 | -4.15 Mn |
| Mar 31, 2024 | -4.60 Mn |
| Dec 31, 2023 | 12.80 Mn |
| Sep 30, 2023 | 6.01 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Dec 31, 2022 | -5.31 Mn |
| Sep 30, 2022 | -293,000.00 |
| Jun 30, 2022 | 9.43 Mn |
| Mar 31, 2022 | -3.37 Mn |
| Dec 31, 2021 | 4.44 Mn |
| Sep 30, 2021 | -44.64 Mn |
| Jun 30, 2021 | -5.07 Mn |